5+ mon, 2+ week ago   (107+ words) Since 1998, this community has helped people find opportunities, build careers, and connect across the industry. As we close this chapter, we do so with gratitude and pride in what we created together. For everyone who found an opportunity here, from…...

3+ mon, 1+ week ago   (473+ words) "One DEA Schedule I laboratory registration approved. FDA INDs granted. Orphan Drug Designation awarded. Yet the cultivation application remains unresolved as patients continue to wait. This is responsible drug policy?" stated Duane Boise, CEO MMJ International Holdings. Anne Milgram is…...

3+ mon, 2+ week ago   (155+ words) Dr. Ran Rubinstein introduces BioRePeel to both New York and New Jersey practices as demand grows for no-downtime skin rejuvenation treatments. A New Option for Patients Who Want Results Without the Downtime What Sets BioRePeel Apart A Peel That Fits…...

3+ mon, 2+ week ago   (560+ words) "After Eight Years, Millions invested, FDA INDs, Orphan Drug Designation, DEA Inspections, and a Completed Federal Investigation, MMJ Demands the Government Explain Why Companies That Followed Federal Law Were Left Behind" asked Duane Boise, CEO MMJ International Holdings. The filing,…...

9+ mon, 1+ week ago   (214+ words) The Roche sponsored phase 1 clinical trial is expected to start in the first half of 2026, initiating the development of a broader platform dedicated to alpha radioimmunotherapies, underscoring Orano Med’s global leading position in the field of targeted alpha therapies. About…...

3+ mon, 2+ week ago   (144+ words) BLEEDnFIRE pioneers first RNA therapy targeting protein S, key regulator of coagulation cascade, offering new therapeutic strategy for patients across multiple rare bleeding disorders Support from Innosuisse and Venture Kick positions BLEEDnFIRE for next stage development and financing round In…...

3+ mon, 2+ week ago   (507+ words) Median is a leading provider of imaging services to the world’s top oncology pharma companiesMedian will host two presentation sessions to introduce its new solutions for radiopharmaceutical image processing and cachexia assessment for oncology research at booth #36102SOPHIA ANTIPOLIS, France--(BUSINESS…...

3+ mon, 2+ week ago   (166+ words) "The Gold Standard - Applied Only to Us" During that same period, state-licensed cannabis operators - operating outside the federal registration system - have seen their products increasingly recognized, reimbursed, and commercially rewarded under the very federal framework MMJ was required to follow....

3+ mon, 2+ week ago   (640+ words) Kvvit to lead local development, regulatory activities and commercialization of INBRIJA® in mainland China, Hong Kong and Macao​Under the agreement, Merz Therapeutics will receive upfront, development and commercial milestone payments, and tiered supply and royalty arrangements, with no manufacturing…...

3+ mon, 2+ week ago   (215+ words) MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today provided a business update and reported its…...